Bratislava Medical Journal Vol.119, No.4, p.201-204, 2018

Published Monthly, in English
Founded: 1919
ISSN 0006-9248
(E)ISSN 1336-0345

Impact factor 1.5

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Bratislava Medical Journal Vol.119, No.4, p.201-204, 2018
Title: Structural aspects of Alzheimer’s disease immunotherapy targeted against amyloid-beta peptide
Author: O. Cehlar, R. Skrabana, V. Revajova, M. Novak

Abstract: Alzheimer’s disease is the most prominent neurodegenerative disease and has no efficient therapies available so far. Immunotherapy against amyloid-β (Aβ) peptide is one of the currently tested therapeutic approaches. Here we have reviewed the available structural knowledge about antibodies tested as passive anti-Aβ immunotherapy in clinical trials. The therapeutic anti-Aβ antibodies differ in their epitope specificity and in recognition and affinity to different Aβ species present in vivo (Tab. 1, Fig. 1, Ref. 17).

Keywords: Alzheimer’s disease, amyloid beta, immunotherapy, antibody-amyloid complex
	Published online: 09-Apr-2018
Year: 2018, Volume: 119, Issue: 4	Page From: 201, Page To: 204
doi:10.4149/BLL_2018_037
	download file

Aepress.sk